Maravai LifeSciences a Aktie

Maravai LifeSciences a für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2QHK8 / ISIN: US56600D1072

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
09.06.2025 14:49:11

Maravai LifeSciences Appoints Bernd Brust To Succeed William Martin III As CEO

(RTTNews) - Maravai LifeSciences Holdings, Inc. (MRVI) announced Monday the appointment of Bernd Brust as Chief Executive Officer (CEO) and a member of the Board of Directors, effective immediately. Brust succeeds William Martin III in these roles.

Bernd, who brings more than 30 years of leadership experience in the life sciences industry, most recently served as Executive Chairman, and previously as CEO, of Antylia Scientific.

Prior to Antylia, Brust served as CEO of Qualicaps, a global manufacturer of pharmaceutical capsules and filling equipment acquired by Mitsubishi Chemical Holdings. He also held senior leadership roles at Life Technologies, including where he led the global commercial organization, as well as executive positions at Invitrogen Corporation and GE Medical Systems.

Analysen zu Maravai LifeSciences Holdings Inc Registered -A-mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel